S&P 500 7,459.94 â–ŧ 73.83 (-0.98%) DOW 52,169.10 â–ŧ 383.87 (-0.73%) NASDAQ 25,535.42 â–ŧ 346.53 (-1.34%) US Markets Closed â€ĸ 05:52 AM ET

BIB

ProShares Ultra Nasdaq Biotechnology

Price Chart
Latest Quote

$100.08

+1.45 (+1.47%)
Current Price
Previous Close $98.63
Open $98.19
Day High $102.00
Day Low $98.19
Volume 8,800
Fetched: 2026-07-18T09:52:35
Fund Information
Quarterly Dividend / Yield N/A / 0.32%
Net Assets $83.66M
Expense Ratio 0.95%
Category Trading--Leveraged Equity
Fund Family ProShares
Net Asset Value $98.90
Premium/Discount 1.19%
Quarterly Dividend Yield 0.32%
P/E Ratio 28.19
Exchange NGM
Recent Price History
Date Close Volume
2026-07-17 $100.08 8,800
2026-07-16 $99.76 2,900
2026-07-15 $100.24 7,500
2026-07-14 $98.80 9,000
2026-07-13 $99.88 16,100
2026-07-10 $102.92 29,100
2026-07-09 $108.49 10,300
2026-07-08 $107.74 20,200
2026-07-07 $109.84 8,500
2026-07-06 $106.34 20,200
2026-07-02 $106.84 20,600
2026-07-01 $100.76 13,200
2026-06-30 $100.74 15,000
2026-06-29 $100.48 11,000
2026-06-26 $98.28 27,300
2026-06-25 $94.16 21,400
2026-06-24 $92.31 24,500
2026-06-23 $89.74 46,000
2026-06-22 $88.01 5,800
2026-06-18 $85.02 11,500
About ProShares Ultra Nasdaq Biotechnology

The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.